Cardea’s BPUs can be configured and integrated at scale into thousands of products and applications that will be used in many different markets - in the field, at the bedside, or at the research bench - and that way enabling solutions once only dreamed of.
The core of BPU™ technology consists of multiple Cardean Transistors™ - that are graphene-based biology-gated field-effect transistors – that gets incorporated small particles of functioning multi-omics biological materials on to it like fx. DNA, RNA, and proteins.
At its core the BPU™ measure molecular binding interactions, that are arguably the common denominator for all biosignal types. That way the BPU™ platform allows for everything from simple measurements like antibody/antigen or DNA test all the way up to advanced multi-omics biosignals like (CRISPR) enzymes, active smell-receptor proteins and measurements like RNA-binding proteins that otherwise has been considered practically impossible.